OSsIRIS Study - A Post-market Clinical Follow-up Investigation.

Recruiting

• Conditions: Surgically Created Bone Defects or Bone Defects/Voids Resulting From Traumatic Injury

• Registration Number: NCT06156904
• Lead Sponsor: GreenBone Ortho S.p.A.

Brief Summary

This is a prospective, observational, non-randomized, multicenter, international post-market clinical follow-up investigation aiming to confirm the performance and safety of the bone substitute b.Bone after implantation in patients in isolation or as a graft expander requiring bone grafting for the treatment of surgically created bone defects or bone defects/voids resulting from traumatic injury to promote healing in the pelvis, upper and lower extremities. Patients enrolled in this clinical investigation will undergo orthopaedic surgery with b.Bone as recommended by the specialist and according to orthopaedic standard procedures. Patients will be evaluated preoperatively and at different time points after the surgery according to the standard practice of the sites. The expected schedule is at month 3, month 6 and month 12. Patients who require longer follow-up and could be subjected to metalwork removal will be evaluated up to 24 months. All safety data will be collected from patient inclusion to the end of the clinical investigation.

All study visits will coincide with any of the patient's routine clinical visits, without interfering with the investigator's clinical duties.

It is planned to enroll 135-193 patients from approximately 15 EU and UK sites.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-11-27
• Study First Submitted QC: 2023-11-27
• Study First Posted: 2023-12-05
• Study Start: 2024-01-31
• Status Verified: 2024-06
• Last Update Submitted: 2024-06-06
• Last Update Posted: 2024-06-07
• Primary Completion: 2027-10
• Study Completion: 2027-10

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

1. Patient is undergoing a standard of care bone grafting with b.Bone for the treatment of surgically created bone defects or bone defects resulting from traumatic injury in the extremities and pelvis according to the approved IFU.
2. Male or female patient ≥ 18 years old.
3. Patients willing and able to attend the standard of care follow-up visits and procedures.
4. Patients who have provided consent to participate in the clinical investigation and to the processing of personal data.

Exclusion Criteria

1. Patients with any conditions in which b.Bone is not indicated according to the contraindications defined in the IFU of b.Bone
2. Patients who are currently enrolled in another clinical investigation/study that would directly interfere with the current clinical investigation, except when the patient is participating in a purely observational study with no associated treatments.
3. Woman who is pregnant or breast-feeding.
4. Patients who, in the opinion of the Investigator, have an existing condition that could affect their ability to complete patient reported questionnaires or be compliant with the standard of care follow-up visits and examinations for the duration of the clinical investigation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Performance of b.Bone by determining the radiographic healing/union after surgery.	12 months	Number and rate of patients with successful bone healing/union observable by X-ray or CT scan.; Radiologic images will be evaluated by the surgeon according to the modified radiographic Union Scale for Tibial fractures (mRUST) classification or the modified Neer classification when applicable.

Secondary Outcome Measures

Name	Time	Method
Clinical outcomes measured by patient-reported outcomes - Quality of Life	Baseline and 3, 6 and 12 months	Change in the patient-reported Quality of Life assessed by Health Questionnaire from baseline to month 3, month 6 and month 12 post-treatment.
Evaluate the safety of b.Bone during the clinical investigation period - rate of reinterventions	Up to 24 months	Rate of reinterventions related to the treatment applied during the clinical investigation
Evaluate the safety of b.Bone during the clinical investigation period - AE and SAE	Up to 24 months	Number and rate of procedure and device-related adverse events (AEs) and Serious adverse events (SAEs) during the clinical investigation period.
Clinical outcomes measured by patient-reported outcomes - Pain	Baseline and 3, 6 and 12 months	Change in the patient-reported pain using the Visual Analoge Scale from baseline to month 3, month 6 and month 12 post-treatment.; Patient-completed questionnaire scoring pain by using 10 cm line. Zero (0) indicates no pain at all and ten (10) the worst pain ever.

Trial Locations

Locations (4)

Trauma Surgery Department - University Hospital Regensburg; 🇩🇪 Regensburg, Germany

BG Klinikum Unfallkrankenhaus Berlin; 🇩🇪 Berlin, Germany

Department of Trauma and Orthopaedic Surgery, Leeds General Infirmary; 🇬🇧 Leeds, United Kingdom

Hull University Teaching Hospitals NHS Trust; 🇬🇧 Hull, United Kingdom